These final results, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two guidance the concept of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-similar disorders. This data isn't a https://neilh172vnc8.p2blogs.com/profile